文献速递神经肿瘤

高增殖潜能无功能垂体腺瘤的中期预后:真的是侵袭性变异型吗?

Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?
PubMed 文献 · J Neurooncol · 2018-01-09

回顾性分析845例无功能垂体腺瘤中53例Ki-67指数>3%的患者(6.3%),比较全切除(n=22)与非全切除(n=31)组,全切除组无进展期显著更长(P<0.001)。伽玛刀放射外科治疗11例中10例无进展,分次照射10例中仅2例无进展且5例死亡,替莫唑胺治疗2例均死亡。

要点

  • 全切除组无进展期显著长于非全切除组(P<0.001)。
  • 伽玛刀放射外科治疗11例中10例保持无进展。
  • 分次照射10例中5例死亡,替莫唑胺2例均死亡。

核心结论

  • 全切除和伽玛刀放射外科可获得良好结局,但不适合伽玛刀放射外科的患者预后极差,开发新的挽救治疗至关重要。

研究设计与样本

  • 回顾性研究,纳入845例初次手术治疗的无功能垂体腺瘤患者,其中53例Ki-67标记指数>3%(6.3%)。
  • 对残留肿瘤未行预防性治疗,随访期间发现肿瘤进展则行挽救治疗。

主要发现

  • 53例中22例保持无进展,31例出现肿瘤进展。
  • 全切除组(n=22)与非全切除组(n=31)比较,全切除组无进展期显著更长(P<0.001)。
  • 伽玛刀放射外科治疗11例,10例保持无进展,1例再生长。
  • 分次照射治疗10例,2例保持无进展,5例死亡(其中3例转化为垂体癌),1例因额叶功能障碍致痴呆,2例进展需额外手术和伽玛刀放射外科。
  • 替莫唑胺治疗2例,均死亡(其中1例转化为垂体癌)。

临床怎么用

  • 作者认为全切除和伽玛刀放射外科可获得良好结局。
  • 作者认为不适合伽玛刀放射外科的患者预后极差,开发新的挽救治疗至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pituitary adenomas with high proliferation rate and rapid growth are well known, but the clinical characteristics, prognosis, and treatment algorithm remain unclear. The clinical characteristics and mid-term prognosis of patients with non-functioning pituitary adenomas with high proliferative potential were retrospectively investigated. This study identified 53 patients with Ki-67 labeling index of > 3% among 845 patients with non-functioning pituitary adenoma (6.3%) initially treated by surgery. Prophylactic treatment was not applied for patients with residual tumor, but salvage treatment was performed if tumor progression was identified within the follow-up period. Twenty-two patients remained progression-free, whereas 31 patients suffered tumor progression. Comparison of gross total removal (n = 22) and non-total removal (n = 31) groups showed significantly longer progression-free period in the former group (P < 0.001). As salvage treatment gamma knife radiosurgery was applied for 11 patients resulting in 10 patients remaining progression-free and regrowth in 1 patient. Fractionated irradiation was applied for 10 patients, resulting in 2 patients remaining progression-free, deaths in 5 patients including 3 of transformation to pituitary carcinoma, dementia in 1 patient caused by frontal lobe dysfunction, and progression in 2 patients requiring additional surgery and gamma knife radiosurgery. Temozolomide was administered in 2 patients, resulting in deaths in both patients including 1 transformation to pituitary carcinoma. Total removal and gamma knife radiosurgery can result in good outcome. However, the prognosis is extremely poor for patients inadequate for gamma knife radiosurgery. Development of new salvage treatments is essential.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ogawa Y, Jokura H, Niizuma K, et al. Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant? J Neurooncol. 2018. PMID: 29318507. doi:10.1007/s11060-017-2740-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。